[1]Patent:WO2004/20432,2004,A1.Locationinpatent:Page/Pagecolumn56
[1]Patent:WO2020/94471,2020,A1
[1]Patent:WO2020/94471,2020,A1.Locationinpatent:Page/Pagecolumn8;19
499995-73-2
284492-22-4
501015-24-3
500770-85-4
300675-28-9 | 7,8-Dichloro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | AA00BE7E | MFCD01911608
223128-32-3 | 4-(Methoxymethoxy)-3,5-dimethylphenylboronic acid | AA00BEA5 | MFCD11856041
205437-60-1 | PHENYL-2-AMINOPROPANE-1,1,2,3,3,3-D6 HCL | AA00BEI2 | MFCD06656387
22049-19-0 | 5-(Ethoxymethyl)quinolin-8-ol | AA00BEPY | MFCD01057783
304462-19-9 | Ave 0991 | AA00BEZG | MFCD27992063
209219-38-5 | Nastorazepide | AA00BF3X | MFCD26142609
210555-94-5 | Phenol, 4-dodecyl-,branched | AA00BF92 | MFCD01106359
289480-64-4 | Treprostinil sodium | AA00BFEA | MFCD08141832
241482-18-8 | IFOSFAMIDE IMPURITY B | AA00BFUP | MFCD02661106
204394-36-5 | Ethyl 4-chloro-2-(pyridin-4-yl)pyrimidine-5-carboxylate | AA00BG6U | MFCD11047092
223673-35-6